Drug Type Small molecule drug |
Synonyms SKL 15508, SKL A4R, SKL-A4R + [1] |
Target |
Action agonists |
Mechanism α7 receptor agonists(Neuronal acetylcholine receptor protein alpha-7 subunit agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 2 | United States | 01 Jul 2014 | |
Cognition Disorders | Phase 2 | United States | - |